Palantir, the NHS, Federated Data Platform: Past, Present and Future

Few technology contracts in the history of the NHS have generated as much interest, scrutiny and hostility as the Federated Data Platform. Awarded to Palantir Technologies in November 2023 with a headline value of up to £330 Million over seven years, the FDP was billed as the digital backbone that would finally join up the NHS's notoriously fragmented data estate. 
  
Nearly three years on, the platform is live in the majority of English acute trusts, NHS England is publishing quarterly benefits figures and yet the political temperature around the contract has never been higher. A cross-party committee of MPs has formally urged the government to walk away. The British Medical Association has instructed doctors to limit their engagement. And a break clause in spring 2027 has turned the second half of 2026 into a decision point that will shape NHS data infrastructure for a decade.
  
We look at how we got here, where the FDP actually stands today and what the next eighteen months are likely to bring.

Future: The Break Clause and the Battle for NHS Data Infrastructure
  
Everything now converges on a single contractual mechanism. The FDP's initial three year term ends in spring 2027, and the government must actively decide whether to trigger the first extension. Ministers have said a decision will come "later this year", that is, in the second half of 2026. 
  
The Health and Social Care Committee wants the break clause exercised in February 2027 and has asked the Department of Health and Social Care to assess whether a replacement contractor could be onboarded by March 2027. 
  
Foxglove, 38 Degrees, Amnesty International and allied campaigns are running coordinated public pressure for exactly that outcome, with tens of thousands of signatories.
  
Three scenarios are plausible.
  
The first is continuation. Ripping out a platform that is live in 139 trusts, mid-way through an elective recovery programme the government has staked its health credibility on, is operationally daunting and politically risky in its own way. The NHS has a £24.9 Million Foundry transition and exit contract on the books, but an actual migration would consume management bandwidth the service does not have. If NHS England can stabilise the evidence base, the independent Imperial College Projects evaluation, a £700,000 contract running from March 2026 to 2029, is meant to do exactly that, ministers may conclude that the least bad option is to extend, extract better terms, and tighten governance around supplier access. The awkward wrinkle is timing: the break clause decision will land before the evaluation reports, meaning the government will decide the FDP's future without the independent evidence it commissioned to judge it.
  
The second scenario is managed exit. The committee's letter matters because it reframes exit as responsible planning rather than ideological rupture, and it noted evidence that some trusts already run alternative systems that match or exceed FDP functionality. The Procurement Act 2023, live since February 2025, gives contracting authorities stronger KPI and transparency tools and is generally friendlier to challenger suppliers. An estimated 150 NHS data, intelligence and AI contracts worth around £400 Million expire within two years, creating a genuine market moment for UK-headquartered analytics vendors, systems integrators and interoperability specialists. A government keen to signal digital sovereignty, a theme gathering force across Europe as dependence on US technology firms becomes a strategic anxiety , might find an exit both substantively defensible and politically useful. Advocacy groups have moved beyond pure opposition into constructive territory: Medact's 2026 paper "Beyond Palantir's FDP" sketches what NHS-controlled, standards-based data infrastructure could look like, drawing on precedents such as OpenSAFELY, the secure analytics environment built on GP data during the pandemic that never moved patient records out of their existing systems. The existence of credible, publicly-articulated alternatives changes the political calculus: ministers can no longer claim there is no other way.
  
For the health technology market, the stakes extend well beyond one contract. The FDP decision will set the tone for how the NHS buys strategic data infrastructure for years. An exit, or even a contested renewal, would validate the challenger ecosystem: UK and European analytics vendors, federated-learning and secure data environment specialists, and the systems integrators who would carry any migration. Investors have noticed, data infrastructure, interoperability and waiting-list optimisation have been among the more resilient corners of UK healthtech dealmaking through 2025 and 2026, precisely because demand is policy driven and durable regardless of which logo sits on the platform. Conversely, a clean extension would confirm the gravitational advantage of incumbency at national scale and likely accelerate consolidation among smaller vendors who conclude they cannot compete head-on for national infrastructure and must instead position as acquirable point solutions within someone else's stack.
  
The third scenario, and perhaps most likely, is a fudge: a short extension paired with a re-procurement process, tougher contractual conditions on supplier access and IP, and a commitment to modular, standards-based architecture that reduces lock-in over time. The critique that the NHS is spending £330 Million on a subscription that leaves it with "no lasting software, intellectual property or internal capability" has cut through with MPs across parties and any continuation will likely have to answer it.

Click here to read the report in full https://www.healthcare.digital/single-post/palantir-the-nhs-federated-data-platform-past-present-and-future